Demerol 50mg/ml for sale online.Demerol 50 mg Sanofi Aventis is the brand name of the prescription drug meperidine.
The drug is use to treat moderate-to-severe pain, help put people to sleep before an operation,
and provide pain relief after childbirth.
Demerol is classified as a Schedule II (C-II) controlled substance.
Demerol belongs to a class of pain medications called opioid analgesics,
which work by binding to receptors on the surface of cells where opium normally binds, and stopping the body from sending pain signals to the brain.
Originally manufactured by Sanofi Aventis, the Food and Drug Administration (FDA) first approved Demerol in 1942.
Warnings and Precautions
Addiction, Abuse, and Misuse
Demerol Injection contains meperidine, a Schedule II controlled substance. As an opioid, Demerol Injection exposes users to the risks of addiction, abuse, and misuse [see Drug Abuse and Dependence (9)].
Although the risk of addiction in any individual is unknown, it can occur in patients appropriately prescribed Demerol Injection. Addiction can occur at recommendable dosages and if the drug is misuse or abuse.
Assess each patient’s risk for opioid addiction, abuse, or misuse prior to prescribing Demerol Injection, and monitor all patients receiving Demerol Injection for the development of these behaviors and conditions. Risks are increase in patients with a personal or family history of substance abuse (including drug or alcohol abuse or addiction) or mental illness (e.g., major depression). The potential for these risks should not, however, prevent the proper management of pain in any given patient. Patients at increase risk may be prescribe opioids such as Demerol Injection, but use in such patients necessitates intensive counseling about the risks and proper use of Demerol Injection along with intensive monitoring for signs of addiction, abuse, and misuse.Demerol 50mg/ml for sale online
Opioids are sought by drug abusers and people with addiction disorders and are subject to criminal diversion. Consider these risks when prescribing or dispensing Demerol Injection. Strategies to reduce these risks include prescribing the drug in the smallest appropriate quantity.
There are no reviews yet.